-
Under a bankruptcy procedure prohibited by courts in part of the country, the Sacklers could be sheltered from opioid lawsuits even without declaring bankruptcy. Some states are crying foul.
-
Attorneys, forensic analysts and other financial experts working for Purdue Pharma spent nearly two years looking for evidence of wrongdoing by the Sacklers. Critics want the findings made public.
-
Kentucky, Ohio, and West Virginia will collectively receive roughly $45 million as part of settlement agreements announced Thursday resolving lawsuits…
-
The corporate consulting giant issued a rare apology for its behind-the-scenes work with Purdue Pharma, maker of OxyContin. One senator called McKinsey's behavior "abhorrent."
-
The controversial deal hashed out between the Department of Justice and the maker of Oxycontin provides hundreds of millions of dollars of relief for communities hit hard by the opioid epidemic.
-
Critics say the settlement doesn't hold company executives or members of the Sackler family accountable for their aggressive marketing of OxyContin, which helped fuel the nation's opioid epidemic.
-
Two newly released sets of government data show that the death toll from the nation’s opioid crisis may finally be dropping and also reveal the scale of…
-
A Kentucky appeals court says the secret testimony from a former president of one of the world's largest manufacturers of dangerously addictive opioid…
-
Tennessee's largest health insurer will stop covering OxyContin prescriptions as part of several measures to combat opioid addiction.BlueCross BlueShield…
-
Tennessee's largest health insurer will stop covering OxyContin prescriptions as part of several measures to combat opioid addiction.BlueCross BlueShield…